期刊文献+

柚皮素通过AMPK通路介导的自噬对顺铂耐药宫颈癌细胞(HeLa/DDP)顺铂耐药性的影响 被引量:9

Effect of naringenin on cisplatin resistance of cervical cancer HeLa/DDP cells via AMPK pathway mediated autophagy
原文传递
导出
摘要 目的探究柚皮素对顺铂耐药宫颈癌细胞(HeLa/DDP)顺铂耐药性的影响,并探究其分子机制。方法体外培养人HeLa/DDP细胞、HeLa细胞,CCK-8法检测不同质量浓度顺铂对HeLa/DDP、He La细胞增殖的影响及不同质量浓度柚皮素对HeLa/DDP细胞增殖的影响。设置对照组、顺铂组(2 mg/L顺铂)、顺铂+柚皮素组(2 mg/L顺铂+60 mg/L柚皮素)和顺铂+柚皮素+AMPK通路抑制剂组(2mg/L顺铂+60mg/L柚皮素+50μmol/LCompoundC);CCK-8法检测各组HeLa/DDP细胞增殖情况;流式细胞仪检测各组HeLa/DDP细胞凋亡情况;蛋白免疫印迹(Westernblotting)法检测各组HeLa/DDP细胞中腺苷酸活化蛋白激酶(AMPK)、p-AMPK、Bcl-2相关X蛋白(Bax)、Beclin1、微管相关蛋白1轻链3(LC3)Ⅰ、LC3Ⅱ蛋白表达情况。结果顺铂对HeLa/DDP细胞、HeLa细胞的半数抑制浓度(IC50)分别在4~8、1~2 mg/L,柚皮素对HeLa/DDP细胞的IC50在30~60mg/L。与对照组相比,顺铂组He La/DDP细胞增殖抑制率、凋亡率及细胞中p-AMPK/AMPK、Bax、Beclin1、LC3Ⅱ蛋白表达水平显著升高(P<0.05),LC3Ⅰ蛋白表达水平显著降低(P<0.05);与顺铂组相比,顺铂+柚皮素组HeLa/DDP细胞增殖抑制率、凋亡率及细胞中p-AMPK/AMPK、Bax、Beclin1、LC3Ⅱ蛋白表达水平显著升高(P<0.05),LC3Ⅰ蛋白表达水平显著降低(P<0.05);与柚皮素组相比,AMPK通路抑制剂组He La/DDP细胞增殖抑制率、凋亡率及细胞中p-AMPK/AMPK、Bax、Beclin1、LC3Ⅱ蛋白表达水平显著降低(P<0.05),LC3Ⅰ蛋白表达水平显著升高(P<0.05)。结论柚皮素可能通过激活AMPK通路介导的自噬反应,与顺铂联用发挥对HeLa/DDP细胞增殖抑制作用及凋亡促进作用。 Objective To investigate the effect of naringenin on cisplatin resistance of cervical cancer He La/DDP cells and its molecular mechanism.Methods HeLa/DDP cells and HeLa cells were cultured in vitro,CCK-8 method was used to detect the effects of different concentrations of cisplatin on the proliferation of HeLa/DDP and He La cells,and the effects of naringenin on the proliferation of HeLa/DDP cells.HeLa/DDP cells were divided into control group,cisplatin group(2 mg/L cisplatin),cisplatin+naringenin group(2 mg/L cisplatin+60 mg/L naringenin)and cisplatin+naringenin+AMPK pathway inhibitor group(2 mg/L cisplatin+60 mg/L naringenin+50μmol/L Compound C).The proliferation of HeLa/DDP cells was detected by CCK-8 method,the apoptosis of HeLa/DDP cells was detected by flow cytometry.Western blotting(WB)method was used to detect the expression of adenosine monophosphate activated protein kinase(AMPK),p-AMPK,Bcl-2 associated X protein(Bax),Beclin1,microtubule-associated protein 1 light chain 3(LC3)I and LC3 II protein in HeLa/DDP cells.Results The IC50 value of cisplatin to HeLa/DDP cells and HeLa cells were 4—8 mg/L and 1—2 mg/L,respectively.IC50 value of naringenin to HeLa/DDP cells was in the range of 30—60 mg/L.Compared with those in the control group,the proliferation inhibition rate,apoptosis rate and the protein expression levels of p-AMPK/AMPK,Bax,Beclin1 and LC3Ⅱin HeLa/DDP cells were significantly higher in cisplatin group(P<0.05),and the expression level of LC3Ⅰprotein was significantly lower(P<0.05).Compared with those in cisplatin group,the proliferation inhibition rate and apoptosis rate of HeLa/DDP cells and the expression levels of p-AMPK/AMPK,Bax,Beclin1 and LC3Ⅱprotein in cisplatin+naringenin group were significantly higher,and the expression level of LC3Ⅰprotein was significantly lower(P<0.05).Compared with those in cisplatin+naringenin group,the proliferation inhibition rate and apoptosis rate of HeLa/DDP cells and the protein expression levels of p-AMPK/AMPK,Bax,Beclin1 and LC3Ⅱwere significantly lower in cisplatin+naringenin+AMPK pathway inhibitor group,the expression level of LC3Ⅰprotein was significantly higher(P<0.05).Conclusion Naringenin can inhibit proliferation and promote apoptosis of HeLa/DDP cells by activating autophagy mediated by AMPK pathway.
作者 贾艳利 李军芳 梁高峰 JIA Yan-li;LI Jun-fang;LIANG Gao-feng(Department of Obstetrics and Gynecology,Mengzhou People’s Hospital,Jiaozuo 454750,China;Department of Clinical Pharmacy,the First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471000,China)
出处 《现代药物与临床》 CAS 2021年第5期878-884,共7页 Drugs & Clinic
基金 国家自然科学基金资助项目(81741147)。
关键词 柚皮素 腺苷酸活化蛋白激酶通路 自噬 宫颈癌 HeLa/DDP细胞 顺铂耐药性 naringenin adenosine monophosphate activated protein kinase pathway autophagy cervical cancer Hela/DDP cells cisplatin resistance
  • 相关文献

参考文献8

二级参考文献39

  • 1李季泓.黄芪的药理作用研究[J].辽宁中医药大学学报,2009,11(4):188-189. 被引量:72
  • 2Mosconi L, Tsui W H, Rusinek H, et al. Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease [J]. Eur JNuclMedMollmaging, 2007, 34(9): 1467-1479.
  • 3Profenno L A, Porsteinsson A P, Faraone S V, et al. Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders [J]. Biol Psychiatry, 2010, 67(6): 505-512.
  • 4Steen E, Terry B M, Rivera E J, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease is this type 3 diabetes? [J]. JAlzheimer's Dis, 2005, 7(1): 63-80.
  • 5Zhao W Q, Townsend M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease [J]. Biochim Biophys Acta, 2009, 1792(5): 482-496.
  • 6Lester-Coll N, Rivera E J, Soscia S J, et al. Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease [J]. JAlzheimer's Dis, 2006, 9(1): 13-33.
  • 7Christensen K B, Petersen R K, Kristiansen K, et al. Identification of bioactive compounds from flowers of Black Elder (Sambucus nigra L.) that activate the human peroxisome proliferator-activated receptor (PPAR) : [J]. Phytother Res, 2010, 24(Suppl 2): 129-132.
  • 8包新民,舒斯云.大鼠脑立体定向[M].北京:人民卫生出版社,1991.
  • 9Kannappan S, Anuradha C V. Naringenin enhances insulin- stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome [J]. EurJNutr, 2010, 49(2): 101-109.
  • 10Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease [J]. NatRevNeurol, 2011, 7(3): 137-152.

共引文献114

同被引文献128

引证文献9

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部